- GX-I7,
The only long-acting interleukin-7 drug - Amplifying number of T-cells and unlimited potential
to be developed in combination with global immuno-oncology drugs
- Bio-better drugs for
driven by
proprietary Long-acting hyFc® platform technology
for rare diseases treatment - GX-E4, the long-acting anemia treatment & GX-H9, growth hormone deficiency treatment are in phase 3 clinical trials.
- Saving lives
by innovative biologics - Brings healthier, better lives,
we’re pursuing new ways to address patients’ most serious health issues
- Sharing values
for better future - Genexine believes responsible and Innovative minds
brings better lives of healthy people and a healthy society of our future